Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
St. James's Place Plc is a British wealth management company specializing in financial advice, fund management, and life insurance services. Headquartered in Cirencester, Gloucestershire, it operates a vertically integrated model through a network of partners, offering products such as unit trusts, insurance bonds, pensions, investment savings accounts, and discretionary fund management. The firm supports clients with comprehensive solutions including investment strategies, retirement planning, inheritance tax mitigation, social care provisions, intergenerational wealth transfer, banking, mortgages, and business advisory services. With over 20 offices across the United Kingdom and international presence in Asia and Dubai, St. James's Place Plc manages approximately £190 billion in assets under management as of December 2024. Founded in 1991 by Mark Weinberg and Mike Wilson with backing from Jacob Rothschild, it has evolved through mergers, acquisitions like Henley Group and Rowan Dartington, and leadership transitions, including CEO Mark FitzPatrick since 2023. The company plays a significant role in the UK financial services sector, serving individual, family, private, and business clients while navigating regulatory landscapes and operational restructurings.
Revenue grew 16.2%, still solid.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
£30.14B
▲ +16.2% YoY
Net Income (TTM)
£531M
▲ +33.4% YoY
Op. Margin
—
ROIC
—
Cash Flow & Balance Sheet
FCF (TTM)
£1.07B
▲ +260.8% YoY
Op. Cash Flow (TTM)
£1.07B
▲ +409.6% YoY
Net Debt
£113M
Cash & Equiv.
£330M
Continue Research